Glycerol 60mg suppositories United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 60mg suppositories

special order - glycerol - suppository - 60mg

Glycerol 50% oral solution United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 50% oral solution

special order - glycerol - oral solution - 500ml/1litre

Glycerol 100% solution for injection 5ml ampoules United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 100% solution for injection 5ml ampoules

special order - glycerol - solution for injection - 1ml/1ml

GLYCEROL Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

glycerol

dasco proprietary limited - glycerol - unknown - glycerol solvent active 0.0 - active constituent

Glycerol 1g suppositories United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 1g suppositories

medihealth (northern) ltd - glycerol - suppository - 700mg

Glycerol 2g suppositories United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 2g suppositories

medihealth (northern) ltd - glycerol - suppository - 1400mg

Glycerol 4g suppositories United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol 4g suppositories

medihealth (northern) ltd - glycerol - suppository - 2800mg

Glycerol liquid United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

glycerol liquid

bell,sons & co (druggists) ltd - glycerol - liquid - 1ml/1ml

Glycerol 4g Suppositories Suppository Kenya - English - Pharmacy and Poisons Board

glycerol 4g suppositories suppository

martindale pharmaceuticals bampton road harold hill romford essex rm3 8ug - glycerol - suppository - 2800mg - other drugs for constipation

Ravicti European Union - English - EMA (European Medicines Agency)

ravicti

immedica pharma ab - glycerol phenylbutyrate - urea cycle disorders, inborn - other alimentary tract and metabolism products, - ravicti is indicated for use as adjunctive therapy for chronic management of patients with urea cycle disorders (ucds) including deficiencies of carbamoyl phosphate-synthase-i (cps), ornithine carbamoyltransferase (otc), argininosuccinate synthetase (ass), argininosuccinate lyase (asl), arginase i (arg) and ornithine translocase deficiency hyperornithinaemia-hyperammonaemia homocitrullinuria syndrome (hhh) who cannot be managed by dietary protein restriction and/or amino acid supplementation alone.ravicti must be used with dietary protein restriction and, in some cases, dietary supplements (e.g., essential amino acids, arginine, citrulline, protein-free calorie supplements).